An important discovery has identified a protein called interleukin-27 as a potent anti-tumor agent that inhibits pediatric B-acute lymphoblastic leukemia of the child.
The discovery is due to a group of researchers, equipe of the Institute Giannini Gaslini in Genoa, coordinated by Dr.Airoldi, head of the Immunology and Cancer Laboratory funded by the Italian Association for Cancer Research.
Interleukin 27 has an important rule in regolating the activity of lymphoid cells B with immuno suppressive properties. The result of the study has been published in the international journal Leukemia and the scientists will soon have clinical implications for patients.
Acute lymphoblastic leukemia is the most common pediatric hematologic cancer. Most children with this leukemia are successfully treated but about 25% of them require alternative therapies.
(Sorce Reuters)
Italoeuropeo
Universal Declaration 
